{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:58:44Z","timestamp":1761821924915,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rec.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T18:50:24Z","timestamp":1560279024000},"page":"889-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Biomarkers for Precision Medicine in Heart Transplant: Is Galectin-3 the One?"],"prefix":"10.1016","volume":"72","author":[{"given":"Avishay","family":"Grupper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2019.05.005_bib0075","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIRCULATIONAHA.117.029964","article-title":"Importance of routine antihuman\/leukocyte antibody monitoring: De novo donor specific antibodies are associated with rejection and allograft vasculopathy after heart transplantation","volume":"136","author":"Wong","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2019.05.005_bib0080","doi-asserted-by":"crossref","first-page":"e13349","DOI":"10.1111\/ctr.13349","article-title":"Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Grupper","year":"2018","journal-title":"Clin Transplant."},{"key":"10.1016\/j.rec.2019.05.005_bib0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"de Boer","year":"2011","journal-title":"Ann Med."},{"key":"10.1016\/j.rec.2019.05.005_bib0090","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2019.05.005_bib0095","doi-asserted-by":"crossref","first-page":"E679","DOI":"10.1111\/ctr.12250","article-title":"Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation","volume":"27","author":"Kobashigawa","year":"2013","journal-title":"Clin Transplant."},{"key":"10.1016\/j.rec.2019.05.005_bib0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jchf.2016.06.010","article-title":"Circulating galectin-3 levels are persistently elevated after heart transplantation and are associated with renal dysfunction","volume":"4","author":"Grupper","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.rec.2019.05.005_bib0105","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.recesp.2018.10.004","article-title":"Circulating galectin-3 following heart transplant: long-term dynamics and prognostic value","volume":"72","author":"Su\u00e1rez-Fuentetaja","year":"2019","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2019.05.005_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12872-016-0298-z","article-title":"Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation","volume":"16","author":"Coromilas","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.rec.2019.05.005_bib0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.amjcard.2011.03.056","article-title":"Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival","volume":"108","author":"Tang","year":"2011","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2019.05.005_bib0120","doi-asserted-by":"crossref","first-page":"e13395","DOI":"10.1111\/ctr.13395","article-title":"Genomewide association study reveals novel genetic loci associated with change in renal function in heart transplant recipients","volume":"32","author":"Asleh","year":"2018","journal-title":"Clin Transplant."},{"key":"10.1016\/j.rec.2019.05.005_bib0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.trim.2011.07.001","article-title":"Intimal fibrosis in human cardiac allograft vasculopathy","volume":"25","author":"Huibers","year":"2011","journal-title":"Transpl Immunol."},{"key":"10.1016\/j.rec.2019.05.005_bib0130","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)01714-X","article-title":"Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome","volume":"39","author":"Yamani","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2019.05.005_bib0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/TP.0b013e318273878c","article-title":"Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study","volume":"95","author":"Topilsky","year":"2013","journal-title":"Transplantation."},{"key":"10.1016\/j.rec.2019.05.005_bib0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/TP.0000000000000047","article-title":"The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection","volume":"98","author":"Fine","year":"2014","journal-title":"Transplantation."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585719301549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585719301549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:56:33Z","timestamp":1761821793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585719301549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1885585719301549"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2019.05.005","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Biomarkers for Precision Medicine in Heart Transplant: Is Galectin-3 the One?","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2018.10.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}